|
|
|
|
| LEADER |
01465nam a22002775i 4500 |
| 001 |
000285324 |
| 005 |
20211118161425.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2008 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783540721468
|
| 024 |
7 |
|
|a 10.1007/978-3-540-72146-8
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Human Antibody Therapeutics For Viral Disease /
|c edited by Scott K. Dessain.
|
| 250 |
|
|
|a 1st ed. 2008.
|
| 260 |
# |
# |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 2008.
|
| 300 |
|
|
|a XII, 190 p. 18 illus., 7 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Current Topics in Microbiology and Immunology,
|v 317
|
| 505 |
0 |
|
|a Therapeutic Control of Hepatitis C Virus: The Role of Neutralizing Monoclonal Antibodies -- Antibodies for HIV Treatment and Prevention: Window of Opportunity? -- Human Monoclonal Antibody and Vaccine Approaches to Prevent Human Rabies -- Immunoprophylaxis of RSV Infection: Advancing from RSV-IGIV to Palivizumab and Motavizumab -- The Molecular Basis of Antibody Protection Against West Nile Virus -- Exploring the Native Human Antibody Repertoire to Create Antiviral Therapeutics.
|
| 650 |
|
0 |
|a Virology.
|
| 650 |
1 |
4 |
|a Virology.
|
| 700 |
1 |
|
|a Dessain, Scott K.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|